Genomic organization, exact localization, and tissue expression of the human CD26 (dipeptidyl peptidase IV) gene
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
CD26 is a lymphocyte cell surface antigen which is increased during T-cell activation and is also expressed in other tissues. It is an atypical serine protease belonging to the prolyl oligopeptidase family. CD26 has been implicated in a variety of biological functions including T-cell activation, cell-to-cell adhesion, and recently in HIV infection. This paper describes, through the isolation and partial sequencing of eight human CD26 genomic clones, the first information on the genomic organization of the prolyl oligopeptidase family. We have established that the human CD26 gene spans approximately 70 kilobases (kb) and contains 26 exons, ranging in size from 45 base pairs (bp) to 1.4 kb. The nucleotides that encode the serine recognition site (G-W-S-Y-G) are split between two exons. This clearly distinguishes the genomic organization of the prolyl oligopeptidase family from that of the classical serine protease family. The 5' flanking domain of the CD26 gene contains neither a TATA box nor a CAAT box, but a 300 bp region extremely rich in C and G (72%) contains potential binding sites for several transcriptional factors. The human CD26 gene encodes two messages sized at about 4.2 and 2.8 kb. These are both expressed at high levels in the placenta and kidney and at moderate levels in the lung and liver. Only the 4.2 kb mRNA was expressed at low levels in skeletal muscle, heart, brain, and pancreas. Fluorescence in situ hybridization on metaphase chromosome spreads located th…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The regulation of DPPIV expression seems to be tissue specific, 28,29 and soluble antigen concentrations may reflect not only expression but also cleavage from the cell surface.”
From Dipeptidyl Peptidase IV in Angiotensin-Converting Enzyme Inhibitor–Associated Angioedema (2008) · cites this paper as [28]
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
Angel, P., Imagawa, M., Chiu, R., Stein, B., Imbra, R. J., Rahmsdorf, H. J., Jonat, C., Herrlich, P., & Karin, M. (1987) · Cell · doi:10.1016/0092-8674(87)90611-8 · Cited by 2,931 · cited 1×
“AP-1 and AP-2 sites have been identif ied in genes whose transcription is induced by phorbol esters, including cellular proto-oncogenes such as c- fos and c - m y c (Angel et al. 1987; Lee et al. 1987).”
Lee, W., Haslinger, A., Karin, M., & Tjian, R. (1987) · Nature · doi:10.1038/325368a0 · Cited by 731 · cited 1×
“AP-1 and AP-2 sites have been identif ied in genes whose transcription is induced by phorbol esters, including cellular proto-oncogenes such as c- fos and c - m y c (Angel et al. 1987; Lee et al. 1987).”
Proline-Dependent Structural and Biological Properties of Peptides and Proteins
Yaron, A., Naider, F., & Scharpe, S. (1993) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239309082572 · Cited by 551
Direct Association of Adenosine Deaminase with a T Cell Activation Antigen, CD26
Kameoka, J., Tanaka, T., Nojima, Y., Schlossman, S. F., & Morimoto, C. (1993) · Science · doi:10.1126/science.8101391 · Cited by 507 · cited 1×
“Furthermore, CD26 has been shown to bind adenosine deaminase ADA; (Morrison et al. 1993; Kameoka et al. 1993).”
SIGNAL SCAN: a computer program that scans DNA sequences for eukaryotic transcriptional elements
Prestridge, D. S. (1991) · Bioinformatics · doi:10.1093/bioinformatics/7.2.203 · Cited by 489
Ishii, S., Xu, Y. H., Stratton, R. H., Roe, B. A., Merlino, G. T., & Pastan, I. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.15.4920 · Cited by 373
CD26: a surface protease involved in T-cell activation
Fleischer, B. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90316-6 · Cited by 325 · cited 2×
“The full spectrum of CD26 function remains unclear (Fleischer 1994).”
Human N-myc is closely related in organization and nucleotide sequence to c-myc
Kohl, N. E., Legouy, E., DePinho, R. A., Nisen, P. D., Smith, R. K., Gee, C. E., & Alt, F. W. (1986) · Nature · doi:10.1038/319073a0 · Cited by 274 · cited 1×
“Promoters of this type are known to regulate the expression of proto-oncogenes such as Pim 1, N-myc, or H-ras (Ishii et al. 1985 a; Kohl et al. 1986; Meeker et al. 1990) and growth factor receptors such as epidermal growth factor receptor (Ishii et al.”
Cited by
Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides
Mentlein, R. (1999) · Regulatory Peptides · doi:10.1016/s0167-0115(99)00089-0 · Cited by 1,272
Lambeir, A.-M., Durinx, C., Scharpé, S., & De Meester, I. (2003) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/713609354 · Cited by 955
“249–251 In vitro, DPP IV rapidly cleaves the N-terminal Tyr-Pro from NPY and PYY, resulting in NPY(3-36) and PYY(3-36).”
BackgroundInfluentialPharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors
Mulvihill, E. E., & Drucker, D. J. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1035 · Cited by 609
“In the mouse, Dpp4 is found on chromosome 2 (2C2–2D), and interestingly, exon 21 and exon 22 are present as a single 156-bp exon (19, 20).”
BackgroundInfluentialCD26, let it cut or cut it down
De Meester, I., Korom, S., Van Damme, J., & Scharpé, S. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01486-3 · Cited by 451
Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system
Klemann, C., Wagner, L., Stephan, M., & von Hörsten, S. (2016) · Clinical and Experimental Immunology · doi:10.1111/cei.12781 · Cited by 425
Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV)
Arabi, Y. M., Harthi, A., Hussein, J., Bouchama, A., Johani, S., Hajeer, A. H., Saeed, B. T., Wahbi, A., Saedy, A., AlDabbagh, T., et al. (2015) · Infection · doi:10.1007/s15010-015-0720-y · Cited by 389
“DPP4 is expressed on T-cells and in the lung, kidney, placenta, liver, skeletal muscle, heart, brain, endothelium, and pancreas [23].”
BackgroundDipeptidyl Peptidase-4 Inhibition and the Treatment of Type 2 Diabetes
Drucker, D. J. (2007) · Diabetes Care · doi:10.2337/dc07-0228 · Cited by 367
“Although administration of NPY produces potent anxiolytic and sedative-like effects in DPP-4–deficient F344 rats (57), there is little evidence that endogenous circulating or tissue levels of NPY(1-36) versus NPY(3-36) are significantly altered following reduction of DPP-4 activity in vivo.”
BackgroundInfluentialCD26: A Multifunctional Integral Membrane and Secreted Protein of Activated Lymphocytes
Gorrell, M. D., Gysbers, V., & McCaughan, G. W. (2001) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2001.00984.x · Cited by 363
Self-citationCunningham, D. F., & O'Connor, B. (1997) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(97)00134-9 · Cited by 336
Levy, M. T., McCaughan, G. W., Abbott, C. A., Park, J. E., Cunningham, A. M., Müller, E., Rettig, W. J., & Gorrell, M. D. (1999) · Hepatology · doi:10.1002/hep.510290631 · Cited by 336
Self-citationThe multifunctional or moonlighting protein CD26/DPPIV
Boonacker, E., & Van Noorden, C. J. F. (2003) · European Journal of Cell Biology · doi:10.1078/0171-9335-00302 · Cited by 337
The prolyl oligopeptidase family
Polgár, L. (2002) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s00018-002-8427-5 · Cited by 311
Abbott, C. A., Yu, D. M. T., Woollatt, E., Sutherland, G. R., McCaughan, G. W., & Gorrell, M. D. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01617.x · Cited by 271
Self-citationTherapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes
Drucker, D. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.1.87 · Cited by 237
“DPP-IV is a widely expressed enzyme present on cells in most tissues, including the kidney, gastrointestinal tract, biliary tract and liver, placenta, uterus, prostate, skin and, of potential relevance to the clinical use of inhibitors, lymphocytes (immune function) and endothelial cells (inactivation of circulating p…”
BackgroundMilk protein-derived opioid receptor ligands
Teschemacher, H., Koch, G., & Brantl, V. (1997) · Biopolymers · doi:10.1002/(sici)1097-0282(1997)43:2<99::aid-bip3>3.0.co;2-v · Cited by 210
Antonioli, L., Colucci, R., La Motta, C., Tuccori, M., Awwad, O., Da Settimo, F., Blandizzi, C., & Fornai, M. (2012) · Current Drug Targets · doi:10.2174/138945012800564095 · Cited by 179
Könönen, E., Fteita, D., Gursoy, U. K., & Gursoy, M. (2022) · Journal of Oral Microbiology · doi:10.1080/20002297.2022.2079814 · Cited by 163
Cheng, H.-C., Abdel-Ghany, M., Elble, R. C., & Pauli, B. U. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.24207 · Cited by 168
Piñeiro-Sánchez, M. L., Goldstein, L. A., Dodt, J., Howard, L., Yeh, Y., & Chen, W.-T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.7595 · Cited by 160
Angiotensin-converting enzyme inhibitor-associated angioedema
Byrd, J. B., Adam, A., & Brown, N. J. (2006) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2006.08.001 · Cited by 160
Molecular cloning of seprase: a serine integral membrane protease from human melanoma
Goldstein, L. A., Ghersi, G., Piñeiro-Sánchez, M. L., Salamone, M., Yeh, Y., Flessate, D., & Chen, W.-T. (1997) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(97)00032-x · Cited by 146
Dipeptidyl Peptidase IV in Angiotensin-Converting Enzyme Inhibitor–Associated Angioedema
Byrd, J. B., Touzin, K., Sile, S., Gainer, J. V., Yu, C., Nadeau, J., Adam, A., & Brown, N. J. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.096552 · Cited by 147
“27 The regulation of DPPIV expression seems to be tissue specific, 28 , 29 and soluble antigen concentrations may reflect not only expression but also cleavage from the cell surface.”
BackgroundZI, F., HE, J., HE, D., LI, Y., YANG, L., & CAI, Z. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3197 · Cited by 141
“3, respectively (41,50).”
Fibroblast Activation Protein-α
Kelly, T. J., Huang, Y., Simms, A. E., & Mazur, A. (2012) · International review of cytology · doi:10.1016/b978-0-12-394308-8.00003-0 · Cited by 158
Clinical Pharmacokinetics and Pharmacodynamics of Vildagliptin
He, Y. (2012) · Clinical Pharmacokinetics · doi:10.2165/11598080-000000000-00000 · Cited by 142
“DPP-4 is a ubiquitous membrane-spanning cell-surface aminopeptidase, widely expressed in many tissues such as the liver, kidney, lung and intestine, and on the surface of capillary endothelial cells and a subset of T lymphocytes.([15-17]) A soluble form of DPP-4 is also present in plasma and other body fluids, which r…”
BackgroundRole of CD26/dipeptidyl peptidase IV in human T cell activation and function
Ohnuma, K. (2007) · Frontiers in bioscience · doi:10.2741/2844 · Cited by 131
“Other organs expressing CD26 include: brain, endothelium, heart, intestine, kidney, liver, lung, skeletal muscle, pancreas, placenta, and lymphocytes (11-15).”
BackgroundLammi, C., Bollati, C., Ferruzza, S., Ranaldi, G., Sambuy, Y., & Arnoldi, A. (2018) · Nutrients · doi:10.3390/nu10081082 · Cited by 124
“DPP-IV, originally characterized as a T-cell differentiation antigen, was later reported to be ubiquitously expressed on the surface of various cell types, such as renal proximal tubules, intestinal epithelial cells, vascular endothelium, biliary caniliculi, alveolar pneumocytes, and skin fibroblasts [1].”
Abbott, C. A., McCaughan, G. W., & Gorrell, M. D. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01166-7 · Cited by 120
Self-citationSeprase complexes in cellular invasiveness
Chen, W., & Kelly, T. J. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1023055600919 · Cited by 118
Mentlein, R. (2004) · International Review of Cytology · doi:10.1016/s0074-7696(04)35004-7 · Cited by 115
“The 5 0 -flanking domain contains neither a TATA box nor a CAAT box, but a 300-bp region extremely rich in C and G (72%) has potential binding sites for several transcription factors, such as NFkB, AP2, or Sp1 (Table V, Abbott et al., 1994; Bö hm et al., 1995) .”
BackgroundInfluentialDipeptidyl peptidase‐IV inhibitors: a major new class of oral antidiabetic drug
IDRIS, I. R., & Donnelly, R. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00705.x · Cited by 124
Patel, B., & Ghate, M. D. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.12.038 · Cited by 117
Antidiabetic treatment with gliptins: focus on cardiovascular effects and outcomes
Fisman, E. Z., & Tenenbaum, A. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0294-0 · Cited by 106
“3 and composed of 26 exons that encode a protein of 766 amino acids [29].”
BackgroundRegulation of Chemokine Activity – A Focus on the Role of Dipeptidyl Peptidase IV/CD26
Metzemaekers, M., Damme, J. V., Mortier, A., & Proost, P. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00483 · Cited by 98
“The gene spans a region of circa 70 kb (174).”
BackgroundAdvances in Understanding the Expression and Function of Dipeptidyl Peptidase 8 and 9
Zhang, H. E., Chen, Y., Keane, F. M., & Gorrell, M. D. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0272 · Cited by 91
“The sequence around the active-site serine is encoded by a single exon in DPP8 and DPP9, but the homologous region in DPP4 and FAP is encoded by 2 exons (3,31), which suggests that DPP8 and DPP9 are the more ancient genes of the 4.”
BackgroundBöhm, S. K., Gum, J. R., Erickson, R. H., Hicks, J. W., & Kim, Y. S. (1995) · Biochemical Journal · doi:10.1042/bj3110835 · Cited by 89
Abbott, C. A., McCaughan, G. W., Levy, M. T., Church, W. B., & Gorrell, M. D. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00902.x · Cited by 87
Self-citationTyrosine 547 Constitutes an Essential Part of the Catalytic Mechanism of Dipeptidyl Peptidase IV
Bjelke, J. R., Christensen, J. F., Branner, S., Wagtmann, N. R., Olsen, C., Kanstrup, A., & Rasmussen, H. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405400200 · Cited by 84
Peptidases: structure, function and modulation of peptide‐mediated effects in the human lung
van der Velden, J., & Hulsmann, A. R. (1999) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.1999.00462.x · Cited by 75
Regulation of CD26/DPPIV gene expression by interferons and retinoic acid in tumor B cells
Bauvois, B., Djavaheri‐Mergny, M., Rouillard, D., Dumont, J., & Wietzerbin, J. (2000) · Oncogene · doi:10.1038/sj.onc.1203292 · Cited by 81
Coronaviruses and the central nervous system
Morgello, S. (2020) · Journal of NeuroVirology · doi:10.1007/s13365-020-00868-7 · Cited by 73
“Only small amounts of DPP4 mRNA are detected in adult human brain relative to other tissues such as the placenta, kidney, lung, and liver (Abbott et al. 1994).”
BackgroundSuppression of lung metastases by the CD26/DPP4 inhibitor Vildagliptin in mice
Jang, J., Baerts, L., Waumans, Y., Meester, I. D., Yamada, Y., Limani, P., Bazo, I. G., Weder, W., & Jungraithmayr, W. (2015) · Clinical & Experimental Metastasis · doi:10.1007/s10585-015-9736-z · Cited by 75
“CD26/DPP4 is a multifunctional transmembrane glycoprotein constitutively expressed on many cell types and within body fluids in a soluble form [4].”
COVID-19: Are we dealing with a multisystem vasculopathy in disguise of a viral infection?
Mondal, R., Lahiri, D., Deb, S., Bandyopadhyay, D., Shome, G., Sarkar, S., Paria, S. R., Thakurta, T. G., Singla, P., & Biswas, S. C. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02210-8 · Cited by 69
Mouse fibroblast‐activation protein
Niedermeyer, J., Enenkel, B., Park, J. E., Lenter, M., Rettig, W. J., Damm, K., & Schnapp, A. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2540650.x · Cited by 69
Dipeptidyl peptidase in autoimmune pathophysiology
Ohnuma, K., Hosono, O., Dang, N. H., & Morimoto, C. (2011) · Advances in clinical chemistry · doi:10.1016/b978-0-12-385855-9.00003-5 · Cited by 76
Worthen, C., Cui, Y., Orringer, J. S., Johnson, T. M., Voorhees, J. J., & Fisher, G. J. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.04.010 · Cited by 68
Renal effects of neuropeptide Y
Bischoff, A., & Michel, M. C. (1998) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240050538 · Cited by 68
Cardiovascular impact of drugs used in the treatment of diabetes
Triggle, C. R., & Ding, H. (2014) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622314546125 · Cited by 67
“DPP-4, also known as CD26, is a 766-amino-acid cell surface membrane-associated, serine-type protease enzyme which is widely, if not ubiquitously, distributed in numerous tissues, including adipocytes, endothelial cells, kidney, intestine, liver, spleen, placenta, adrenal glands and lymphocytes [Abbott et al. 1994].”
BackgroundRegulation of adenosine receptor engagement by ecto‐adenosine deaminase
Hashikawa, T., Hooker, S. W., Maj, J. G., Knott‐Craig, C. J., Takedachi, M., Murakami, S., & Thompson, L. F. (2003) · The FASEB Journal · doi:10.1096/fj.03-0011fje · Cited by 63
“CD26 has a broad tissue distribution, including kidney, small intestine, lung, spleen, liver, skeletal muscle, and heart, as well as activated T cells (38).”
BackgroundAertgeerts, K., Ye, S., Shi, L., Prasad, S. G., Witmer, D., Chi, E., Sang, B., Wijnands, R. A., Webb, D. R., & Swanson, R. V. (2003) · Protein Science · doi:10.1110/ps.03352504 · Cited by 66
“…also called adenosine deaminase binding protein (ADAbp) or CD26, is a 220-kD homodimeric, type II transmembrane glycoprotein, widely expressed on the surface of a variety of epithelial, endothe- lial, and lymphoid cell types (Abbott et al. 1994; De Meester et al. 1999; Langer and Ansorge 2002).”
BackgroundDipeptidyl Peptidase 4 (DPP4) as A Novel Adipokine: Role in Metabolism and Fat Homeostasis
Barchetta, I., Cimini, F. A., Dule, S., & Cavallo, M. G. (2022) · Biomedicines · doi:10.3390/biomedicines10092306 · Cited by 55
“3) [3] and is preceded by a promoter region controlled by transcription factors such as the nuclear factor kappa-light-chain enhancer of activated B cells (NF-κB) [4], the hepatocyte nuclear factor 1β (HFN1β) [5], the lysine acetyltransferase 5 (KAT5) [6], and the signal transducers and activators of transcription 1α…”
BackgroundLammi, C., Bollati, C., Gelain, F., Arnoldi, A., & Pugliese, R. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00670 · Cited by 57
“This ectoenzyme (EC 3.4.14.5), ubiquitously expressed on the surface of various cell types, such as intestinal epithelial cells (Abbott et al., 1994), cleaves dipeptides from the N-terminus of polypeptides in which proline is at the penultimate position.”
BackgroundInfluentialTurcot, V., Bouchard, L., Faucher, G., Tchernof, A., Deshaies, Y., Përusse, L., Bélisle, A., Marceau, S., Biron, S., Lescelleur, O., et al. (2010) · Obesity · doi:10.1038/oby.2010.198 · Cited by 56
“Investigations into the actions of glucose-dependent insulinotropic polypeptide and glucagonlike peptide-1(7-36)amide on lipoprotein lipase activity in explants of rat adipose tissue.”
BackgroundDPPIV, seprase, and related serine peptidases in multiple cellular functions
Chen, W., Kelly, T. J., & Ghersi, G. (2003) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(03)54010-8 · Cited by 53
Bauvois, B., Meester, I. D., Dumont, J., Rouillard, D., Zhao, H., & Bosmans, E. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690167 · Cited by 51
Insight into the role of DPP-4 in fibrotic wound healing
Zhang, K., Liu, S., Jia, Y., Zou, M., Teng, Y., Chen, Z.-H., Li, Y., Guo, D., Wu, J., Yuan, Z., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113143 · Cited by 52
CD26 and Asthma: a Comprehensive Review
Nieto‐Fontarigo, J. J., González‐Barcala, F. J., José, E. S., Arias, P., Nogueira, M., & Salgado, F. J. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-016-8578-z · Cited by 54
Lambeir, A., Pereira, J. F. D., Chacón, P., Vermeulen, G., Heremans, K., Devreese, B. V., BEEUMEN, J. V., Meester, I. D., & Scharpé, S. (1997) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(97)00045-9 · Cited by 57
Jang, J., Janker, F., Meester, I. D., Arni, S., Borgeaud, N., Yamada, Y., Bazo, I. G., Weder, W., & Jungraithmayr, W. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz009 · Cited by 54
“CD26/ dipeptidyl peptidase 4 (DPP4) is a ubiquitously expressed transmembrane exopeptidase on the cell surface of many hematopoietic cells but also on organs (11).”
BackgroundLotfy, M. A., Singh, J., Kalász, H., Tekes, K., & Adeghate, E. A. (2011) · The Open Medicinal Chemistry Journal · doi:10.2174/1874104501105010082 · Cited by 51
“DPP-4 inhibitors exert their hypoglycaemic effect indirectly by improving the longevity, plasma concentration and action of incretins [55].”
BackgroundReview: The Role of Membrane Peptidase in Immune Functions
Lendeckel, U., Kähne, T., Riemann, D., Neubert, K., Arndt, M., & Reinhold, D. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-46826-3_1 · Cited by 45
DPP IV inhibitors: Successes, failures and future prospects
Kshirsagar, A. D., Aggarwal, A. S., Harle, U. N., & Deshpande, A. D. (2011) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2012.02.017 · Cited by 44
Lei, Y., Hu, L., Yang, G., Piao, L., Jin, M., & Cheng, X. W. (2017) · Circulation Journal · doi:10.1253/circj.cj-16-1326 · Cited by 45
Marciano, Y., del Solar, V., Nayeem, N., Dave, D. R., Son, J., Contel, M., & Ulijn, R. V. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c09820 · Cited by 42
Elmansi, A. M., Awad, M. E., Eisa, N. H., Kondrikov, D., Hussein, K. A., Aguilar‐Perez, A., Herberg, S., Periyasamy‐Thandavan, S., Fulzele, S., Hamrick, M. W., et al. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.02.005 · Cited by 40
Tsuji, T., Sugahara, K., Tsuruda, K., Uemura, A., Harasawa, H., Hasegawa, H., Hamaguchi, Y., Tomonaga, M., Yamada, Y., & Kamihira, S. (2004) · International Journal of Hematology · doi:10.1532/ijh97.04066 · Cited by 42
“The gene contains 26 exons ranging in size from 45 base pairs to 1.4 kilobase pairs [ 4 ].”
BackgroundInfluentialWagner, L., Kaestner, F., Wolf, R., Stiller, H., Heiser, U. F., Manhart, S., Hoffmann, T., Rahfeld, J., Demuth, H., Rothermundt, M., et al. (2016) · Neuropeptides · doi:10.1016/j.npep.2016.02.007 · Cited by 40
Adenosine Neuromodulation and Traumatic Brain Injury
Lusardi, T. A. (2009) · Current Neuropharmacology · doi:10.2174/157015909789152137 · Cited by 39
“Of interest, colocalization of ADA, the A1 receptor, and the cytokine CD26 (also known as dipeptidyl peptidase IV, DPPIV) has been noted in many organs and across species [1, 16].”
BackgroundMarino, M. T., Costello, D. G., Baughman, R., Boss, A., Cassidy, J., D'Amico, C., van Marle, S., van Vliet, A., & Richardson, P. C. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.85 · Cited by 37
Chapter 19. DPP-IV inhibition and therapeutic potential
Villhauer, E. B., Coppola, G. M., & Hughes, T. E. (2001) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(01)36059-1 · Cited by 36
Regulation and roles of CD26/DPPIV in hematopoiesis and diseases
Serej, Z. A., Kalan, A. E., Mehdipour, A., & Charoudeh, H. N. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.04.074 · Cited by 36
Neurologic complications of coronavirus and other respiratory viral infections
Cavallieri, F., Sellner, J., Zedde, M., & Moro, E. (2022) · Handbook of clinical neurology · doi:10.1016/b978-0-323-91532-8.00004-5 · Cited by 36
“DPP4 is widely expressed in many tissues and organs including lungs, kidneys, placenta, liver, skeletal muscles, heart, brain (both neurons and astrocytes), endothelium, T lymphocytes, and pancreas (Abbott et al., 1994).”
BackgroundIdentification of an Alternatively Spliced Seprase mRNA That Encodes a Novel Intracellular Isoform
Goldstein, L. A., & Chen, W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2554 · Cited by 34
The Serine Protease CD26/DPP4 in Non-Transformed and Malignant T Cells
Chitadze, G., Wehkamp, U., Janßen, O., Brüggemann, M., & Lettau, M. (2021) · Cancers · doi:10.3390/cancers13235947 · Cited by 35
Fish proglucagon genes have differing coding potential
Li, Z., & Irwin, D. M. (2004) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpc.2003.11.009 · Cited by 31
GLP-1R activation for the treatment of stroke: Updating and future perspectives
Darsalia, V., Nathanson, D., Nyström, T., Klein, T., Sjöholm, Å., & Patrone, C. (2014) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-014-9285-9 · Cited by 31
“Expression of DPP-4 in the human brain was originally thought to be limited [117].”
BackgroundDepletion of polyfunctional CD26highCD8+ T cells repertoire in chronic lymphocytic leukemia
Bozorgmehr, N., Hnatiuk, M., Peters, A., & Elahi, S. (2023) · Experimental Hematology and Oncology · doi:10.1186/s40164-023-00375-5 · Cited by 34
“CD26 is widely expressed by various cells in different tissues including fibroblasts, endothelial, epithelial, mesothelial, and immune cells [5].”
BackgroundPugliese, R., Bollati, C., Gelain, F., Arnoldi, A., & Lammi, C. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b07264 · Cited by 29
Guttula, S. V., Rao, A. A., Sridhar, G. R., Chakravarthy, M., Nageshwararo, K., & Rao, P. V. S. (2010) · International Journal of Diabetes in Developing Countries · doi:10.4103/0973-3930.60003 · Cited by 30
“Dipeptidyl-peptidase 4 (CD26, adenosine deaminase complexing protein 2),[13] ENSA: Endosulfi ne alpha,[14]”
Expression of CD26/dipeptidyl-peptidase IV in benign and malignant pigment-cell lesions of the skin
Oord, V. D. (1998) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1998.02171.x · Cited by 29
Fteita, D., Könönen, E., Gürsoy, M., Söderling, E. M., & Gürsoy, U. K. (2015) · Anaerobe · doi:10.1016/j.anaerobe.2015.09.002 · Cited by 27
Chakraborty, C., Hsu, M. J., & Agoramoorthy, G. (2014) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-014-9998-0 · Cited by 27
Leukocyte Membrane Enzymes Play the Cell Adhesion Game
López-Cortés, G. I., Díaz-Alvarez, L., & Ortega, E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.742292 · Cited by 26
“CD26 is expressed on the endothelium, epithelial cells of the kidney, liver, lung, intestine and on T cells, some B and NK cells, as well as on myeloid cells (37).”
BackgroundOverexpression of CD26/DPPIV in mesothelioma tissue and mesothelioma cell lines
Amatya, V. J. (2011) · Oncology Reports · doi:10.3892/or.2011.1449 · Cited by 26
Lettau, M., Dietz, M., Vollmers, S., Armbrust, F., Peters, C., Dang, T., Chitadze, G., Kabelitz, D., & Janßen, O. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03207-0 · Cited by 25
The Family of CD26/DPIV and Related Ectopeptidases
Abbott, C. A., & Gorrell, M. D. (2002) · Springer eBooks · doi:10.1007/978-1-4615-0619-5_7 · Cited by 25
Self-citationExtracellular signaling in Dictyostelium
Consalvo, K. M., Rijal, R., Tang, Y., Kirolos, S. A., Smith, M., & Gomer, R. H. (2019) · The International Journal of Developmental Biology · doi:10.1387/ijdb.190259rg · Cited by 25
“DPPIV is present in plasma and other extracellular fluids (Abbott et al., 1994, Cordero et al., 2009).”
BackgroundDemangel, C., Rouyre, S., Alzari, P. M., Nato, F., Longacre, S., Lafaye, P. J., & Mazié, J. C. (1998) · Biological Chemistry · doi:10.1515/bchm.1998.379.1.65 · Cited by 24
Chen, X., He, Z., Zhou, Z., Yang, T., Zhang, X., Yang, Y., Duan, W., & Zhou, S. (2015) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12469 · Cited by 24
Quassia amara bioactive compounds as a Novel DPP-IV inhibitor: an in-silico study
Olugbogi, E. A., Bodun, D. S., Omoseeye, S. D., Onoriode, A. O., Oluwamoroti, F. O., Adedara, J. F., Oriyomi, I. A., Bello, F. O., Olowoyeye, F. O., Laoye, O. G., et al. (2022) · Bulletin of the National Research Centre/Bulletin of the National Research Center · doi:10.1186/s42269-022-00890-1 · Cited by 26
CD26 expression and dipeptidyl peptidase IV activity in an aggressive hepatosplenic T-cell lymphoma
Ruiz, P., Mailhot, S., Delgado, P., Amador, A. C., Viciana, A. L., Ferrer, L., & Zacharievich, N. (1998) · Cytometry · doi:10.1002/(sici)1097-0320(19980215)34:1<30::aid-cyto5>3.0.co;2-i · Cited by 23
Elevated serum dipeptidyl peptidase IV (CD26, EC 3.4.14.5) activity in experimental liver cirrhosis
Lakatos, P. L., Firneisz, G., Borcsiczky, Zalatnai, Selmeci, & Szalay (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00698.x · Cited by 26
Roles of cysteines in rat dipeptidyl peptidase IV/CD26 in processing and proteolytic activity
Dobers, J., Grams, S., Reutter, W. G., & Fan, H. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01571.x · Cited by 23
Bender, V., Büschlen, S., & Cassio, D. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.22.3437 · Cited by 23
Du, J., Fu, J., Zhang, W., Zhang, L., Chen, H., Cheng, J., He, T., & Fu, J. (2023) · International Journal of Oncology · doi:10.3892/ijo.2023.5489 · Cited by 22
“2 and encodes a protein composed of 766 amino acids with a predicted molecular weight of 88,279 Da (4).”
Structure and Localization of the Mouse Prolyl Oligopeptidase Gene
Kimura, A. P., Yoshida, I., Takagi, N., & Takahashi, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24047 · Cited by 26
Expression of Attractin and Its Differential Enzyme Activity in Glioma Cells
Malík, R., Mareš, V., Kleibl, Z., Pohlreich, P., Vlasicova, K., & Šedo, A. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4956 · Cited by 21
Structure of CD26 (Dipeptidyl Peptidase IV) and Function in Human T Cell Activation
Hegen, M., Kameoka, J., Dong, R.-P., Morimoto, C., & Schlossman, S. F. (1997) · Advances in experimental medicine and biology · doi:10.1007/978-1-4757-9613-1_15 · Cited by 21
Ayoub, B. M., Michel, H. E., Mowaka, S., Hendy, M. S., & Tadros, M. M. (2021) · Molecules · doi:10.3390/molecules26040889 · Cited by 22
Kertész, Z., Linton, E. A., & Redman, C. W. G. (2000) · Placenta · doi:10.1053/plac.1999.0476 · Cited by 20
Metadata
- Authors
- Abbott, C. A., McCaughan, G. W., Baker, E., & Sutherland, G. R.
- Affiliations
- Royal Prince Alfred Hospital (AU)
- Women's and Children's Hospital (AU)
- Venue
- Immunogenetics
- Published
- 1994-09
- Volume
- 40
- Issue
- 5
- Pages
- 331-338
- ISSN
- 0093-7711 (ISSN-L)
- 1432-1211
- OpenAlex
- W2027150840
- Cited by
- 177
- References
- 46
- Citations by year
- 2026: 2 · 2024: 6 · 2023: 7 · 2022: 9 · 2021: 6 · 2020: 8 · 2019: 6 · 2018: 2 · 2017: 10 · 2016: 8 · 2015: 8 · 2014: 8 · 2013: 3 · 2012: 5
- FWCI
- 2.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Immunogenetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Health and Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Peptidase Inhibition and Analysis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- CD26, dipeptidyl peptidase IV, gene structure, exon-intron organization, serine protease, T cell activation, tissue expression, 5'-flanking region, transcriptional regulatory elements, gene mapping, HIV infection
- MeSH terms
- Amino Acid Sequence, Base Sequence, Chromosomes, Human, Pair 2, Cloning, Molecular, Exons, Humans, Introns, Male, Molecular Sequence Data, Restriction Mapping, DNA Probes, Genome, Dipeptidyl Peptidase 4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.